Cardio Diagnostics Holdings, Inc. CDIO
1.95
0.04
2.09%
as of 25 Sep
- Market cap
- $5.7M
- P/E
- 0.0×
Follow CDIO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(110.70%) | (78.62%) | (65.59%) | (75.44%) | |
| (98.75%) | (70.70%) | (60.91%) | (70.62%) | ||
ROIC |
(227.44%) | (217.55%) | (227.16%) | (219.40%) | |
Return on Tangible Assets |
(90.08%) | (108.02%) | (84.08%) | (100.86%) | |
Average Days of Receivables |
258.73 | 198.42 | 93.98 | 97.50 | |
Free Cash Flow per Share |
(3.38) | (3.38) | (2.14) | (1.97) | |
Free Cash Flow |
(5.95) | (5.91) | (6.07) | (5.82) | |
Capital Expenditures |
(0.19) | (0.19) | (0.18) | (0.16) | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(39.69%) | (47.39%) | (36.85%) | (43.49%) | |
Accounts Receivable Turnover |
1.25 | 1.12 | 2.40 | 1.74 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 5,760.40% | 4,616.77% | 5,582.88% | |
Selling, General and Administrative Expense of Revenue |
37,783.54% | 38,876.51% | 35,793.41% | 39,817.12% | |
Share Based Compensation of Revenue |
687.34% | 739.60% | 624.55% | 670.55% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.88 | 0.88 | 0.89 | 0.87 | |
Depreciation/Fixed assets |
0.52 | 0.57 | 0.56 | 0.61 | |
Capex/Depreciation |
(0.49) | (0.47) | (0.50) | (0.44) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.00 | |
Operating CF per Share |
(3.27) | (3.27) | (2.07) | (1.91) | |
Capex per Share |
(0.11) | (0.11) | (0.06) | (0.06) | |
Capex to Sales |
12.09 | 12.57 | 10.98 | 11.27 | |
Net Profit Margin |
(41,468.99%) | (43,612.08%) | (39,828.14%) | (44,312.33%) |
Columns are period end dates